Devon A. Sherwood, PharmD, BCPP Associate Professor of Pharmacy Practice University of New England College of Pharmacy Portland, ME
Searching for Solutions
Natalie Valentino, PharmD, BCPP VA Salt Lake City Healthcare System
Melissa Cloyd, PharmD, BCPS, BCPP, BCGP, DPLA Assistant Pharmacy Director Riverside University Health System – Moreno Valley, CA
What I Wish I Knew: Alternate Career Paths for Psychiatric Pharmacists: Continuing Medical Education
Amber Lemons, PharmD, BCPP Clinical Pharmacist Specialist Psychiatry Children’s Hospital Colorado Aurora, CO
Denver Shipman PharmD, BCPP Clinical Pharmacist Practitioner Robert J. Dole VA Medical Center Wichita, KS
What you need to know about dementia.
What you need to know about vaccinations.
What you need to know about alcohol use disorder.
What you need to know about catatonia.
What you need to know about the end of medication treatment.
Many individuals with hepatic impairment are impacted by psychiatric disorders. Co-occurring substance use disorders are also prevalent and have been associated with increased risk of liver disease. Though limited, literature exists to support safe medication prescribing in patients with hepatic dysfunction, including those with cirrhosis.
Tanya J. Fabian, PharmD, PhD, BCPP Director, Pharmacy Research and Pharmacy Services Director, PGY2 Psychiatric Pharmacy Residency UPMC Western Psychiatric Hospital Associate Professor of Pharmacy & Therapeutics and Psychiatry University of Pittsburgh Schools of Pharmacy and Medicine
The MSL Perspective Brittany Finocchio, PharmD, BCPP Medical Science Liaison Karuna Therapeutics Inc The Woodlands, TX
Ashley Maister, BS, PharmD, BCPP Clinical Pharmacy Practitioner, Psychiatry Corporal Michael J. Crescenz Veterans Affairs Medical Center Philadelphia, Pennsylvania
Carolanne Wartman, PharmD, BCPS, BCPP (she/her) Clinical Assistant Professor of Pharmacy Practice The University of Mississippi School of Pharmacy Jackson, MS
Kaitlyn Q. Weslosky, PharmD, BCPP Clinical Pharmacy Provider- Psychiatry Robert J. Dole VA Medical Center Wichita, KS
What you need to know about Stimulant Use Disorder Treatment.
Julie Thiel, BS Pharm, PharmD State of Wisconsin Department of Health Services, Division of Public Health, Bureau of Community Health Promotion, Family Health Section, Children and Youth with Special Health Care Needs Unit Supervisor Madison, WI
What you need to know about Nonpharmacological/Alternative Treatment Options.
What you need to know about Antipsychotic Induced Weight Gain.
What you need to know about Psychedelic Therapies: Safety and Legality of Psychedelic Compounds.
What you need to know about Accessing Mental Health Treatment.
What you need to know about Harm Reduction for People Who Use Drugs (PWUD).
American Academy of Neurology Practice parameter: Antiepileptic drug prophylaxis in severe traumatic brain injury | Neurology American College of Emergency Physicians (ACEP)
American Academy of Neurology (AAN) Oral and topical treatment of painful diabetic polyneuropathy practice guidelines (2021) American Diabetes Association